168 related articles for article (PubMed ID: 33472814)
1. Function and Expression of Bile Salt Export Pump in Suspension Human Hepatocytes.
Chothe PP; Pemberton R; Hariparsad N
Drug Metab Dispos; 2021 Apr; 49(4):314-321. PubMed ID: 33472814
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
[TBL] [Abstract][Full Text] [Related]
3. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
[TBL] [Abstract][Full Text] [Related]
4. Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes.
Marion TL; Perry CH; St Claire RL; Yue W; Brouwer KL
Toxicol Sci; 2011 Apr; 120(2):371-80. PubMed ID: 21262925
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters.
Leuenberger M; Häusler S; Höhn V; Euler A; Stieger B; Lochner M
J Pharmacol Exp Ther; 2021 Jun; 377(3):346-357. PubMed ID: 33782042
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates.
Chatterjee S; Bijsmans IT; van Mil SW; Augustijns P; Annaert P
Toxicol In Vitro; 2014 Mar; 28(2):218-30. PubMed ID: 24211540
[TBL] [Abstract][Full Text] [Related]
8. Identification of Bile Acids Responsible for Inhibiting the Bile Salt Export Pump, Leading to Bile Acid Accumulation and Cell Toxicity in Rat Hepatocytes.
Oizumi K; Sekine S; Fukagai M; Susukida T; Ito K
J Pharm Sci; 2017 Sep; 106(9):2412-2419. PubMed ID: 28552691
[TBL] [Abstract][Full Text] [Related]
9. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
Cheng Y; Woolf TF; Gan J; He K
Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
[TBL] [Abstract][Full Text] [Related]
10. Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures.
Liu J; Lu H; Lu YF; Lei X; Cui JY; Ellis E; Strom SC; Klaassen CD
Toxicol Sci; 2014 Oct; 141(2):538-46. PubMed ID: 25055961
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
[TBL] [Abstract][Full Text] [Related]
12. A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery.
Hafey MJ; Houle R; Tanis KQ; Knemeyer I; Shang J; Chen Q; Baudy A; Monroe J; Sistare FD; Evers R
Drug Metab Dispos; 2020 Nov; 48(11):1147-1160. PubMed ID: 32943412
[TBL] [Abstract][Full Text] [Related]
13. Vesicle- and Hepatocyte-Based Assays for Identification of Drug Candidates Inhibiting BSEP Function.
Van Brantegem P; Deferm N; Qi B; De Vocht T; Annaert P
Methods Mol Biol; 2019; 1981():55-73. PubMed ID: 31016647
[TBL] [Abstract][Full Text] [Related]
14. Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.
Wu ZT; Yao D; Ji SY; Ni X; Gao YM; Hui LJ; Pan GY
Cell Physiol Biochem; 2016; 38(5):1815-30. PubMed ID: 27160211
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter.
Inokuchi A; Hinoshita E; Iwamoto Y; Kohno K; Kuwano M; Uchiumi T
J Biol Chem; 2001 Dec; 276(50):46822-9. PubMed ID: 11590139
[TBL] [Abstract][Full Text] [Related]
16. Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats.
Yang F; Takeuchi T; Tsuneyama K; Yokoi T; Oda S
Toxicol Sci; 2019 Jul; 170(1):95-108. PubMed ID: 30985903
[TBL] [Abstract][Full Text] [Related]
17. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
Stieger B
Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
[TBL] [Abstract][Full Text] [Related]
18. Hepatic transport of bile salts.
Kullak-Ublick GA; Stieger B; Hagenbuch B; Meier PJ
Semin Liver Dis; 2000; 20(3):273-92. PubMed ID: 11076396
[TBL] [Abstract][Full Text] [Related]
19. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.
Schuetz EG; Strom S; Yasuda K; Lecureur V; Assem M; Brimer C; Lamba J; Kim RB; Ramachandran V; Komoroski BJ; Venkataramanan R; Cai H; Sinal CJ; Gonzalez FJ; Schuetz JD
J Biol Chem; 2001 Oct; 276(42):39411-8. PubMed ID: 11509573
[TBL] [Abstract][Full Text] [Related]
20. Bosentan Alters Endo- and Exogenous Bile Salt Disposition in Sandwich-Cultured Human Hepatocytes.
Oorts M; Van Brantegem P; Deferm N; Chatterjee S; Dreesen E; Cooreman A; Vinken M; Richert L; Annaert P
J Pharmacol Exp Ther; 2021 Oct; 379(1):20-32. PubMed ID: 34349015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]